相关实验视频
Updated: Jan 15, 2026

07:13
3D Modeling of Dendritic Spines with Synaptic Plasticity
Published on: May 18, 2020
7.3K
通过几何空间感知扩散模型设计高亲和度3D药物分子
Hao Lu1, Zhiqiang Wei1, Jiaming Liu1
1College of Computer Science and Technology, Ocean University of China, Songling Road, 266100 Shandong Province, China.
Briefings in bioinformatics
|October 15, 2025
概括
这项研究引入了一种新的扩散模型,使用SE(3) -等价图神经网络用于药物发现. 该模型增强了对蛋白质标的分子结合亲和力,性能优于现有方法,并且在宏循环结构方面表现出色.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 医学中的人工智能
背景情况:
- 为蛋白质标设计高亲和度分子对于药物发现至关重要.
- 当前的3D分子设计方法难以准确地表示欧几里德空间中的联体位.
- 了解3D原子相互作用是改善分子设计的关键.
研究的目的:
- 开发一种扩散模型,增强分子与蛋白质标的结合亲和力.
- 为了改善3D空间中连接体分子位置的表示.
- 设计具有改进的结合亲和力和类似药物的特性的分子.
主要方法:
- 使用基于SE(3) -等效图形神经网络的扩散模型.
- 整合了远程和距离感知注意力头组合,以增强亲和力.
- 实施了分子几何特征增强策略,以改善空间感知.
主要成果:
- 拟议的模型在各种亲和度指标中超过了CrossDocked2020数据集上的最先进方法.
- 在设计具有宏循环结构的配体分子方面取得了卓越的性能.
- 保持了基本的类似药物的特性,并提供了约束相互作用的适度解释性.
结论:
- 新的扩散模型显著提高了用于药物发现的高亲和性分子的设计.
- 模型捕获3D空间信息的能力提高了分子设计的准确性.
- 这种方法为开发具有可解释的结合机制的有效治疗方法提供了一个有希望的方向.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Molecular Models
43.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.5K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
500
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
500
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
332
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
332
Factors Influencing Drug Absorption: Physicochemical Parameters
818
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
818

